Christopher M. Gomez to Clinical Trials as Topic
This is a "connection" page, showing publications Christopher M. Gomez has written about Clinical Trials as Topic.
Connection Strength
0.064
-
Natural History of Friedreich Ataxia: Heterogeneity of Neurologic Progression and Consequences for Clinical Trial Design. Neurology. 2022 Oct 03; 99(14):e1499-e1510.
Score: 0.036
-
Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design. Mov Disord. 2010 Mar 15; 25(4):426-32.
Score: 0.015
-
Antioxidant use in Friedreich ataxia. J Neurol Sci. 2008 Apr 15; 267(1-2):174-6.
Score: 0.013